Japan's Ono collaborates with Jorna Therapeutics to generate novel RNA editing therapeutics

Japan-based Ono Pharmaceutical has entered into a research collaboration agreement with US-based startup Jorna The...

April 22, 2025 | Tuesday | News
Japan's PRISM BioLab and Elix join forces to accelerate AI-driven drug discovery

Japan-based PRISM BioLab, a leading discovery and development biotechnology company designing small molecule inhibitors ...

April 14, 2025 | Monday | News
Engine Biosciences and Experimental Drug Development Centre partner to advance cancer therapies

Engine Biosciences (Engine), a Singapore- and Silicon Valley-based biotechnology company pioneering precision medic...

April 8, 2025 | Tuesday | News
HiRO and Hallym University Sacred Heart Hospital to advance drug development in Korea

Harvest Integrated Research Organization (HiRO), a boutique global CRO, has signed an Memorandum of Understanding (MoU) ...

March 21, 2025 | Friday | News
Insilico Medicine secures $110 M Series E financing to advance AI-driven drug discovery innovation

Insilico Medicine, a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, has successfu...

March 13, 2025 | Thursday | News
Korean firm LG to develop AI model for protein multistate structure prediction

LG AI Research recently signed a joint research agreement at the Global Lounge of LG Science Park in Magok, Gangseo-gu,&...

February 9, 2025 | Sunday | News
Chugai and GSK sign collaboration agreement for anti-dengue virus antibody AID351

Japan's Chugai Pharmaceutical Co. has signed a collaboration agreement with GSK's Global Health Unit (GSK GH) for&n...

January 31, 2025 | Friday | News
“There remains a high unmet need for new & alternative treatment options for prurigo nodularis & atopic dermatitis”

What major plans are in store for the company (Asia Pacific region & global) in 2025? We’re going to keep del...

February 1, 2025 | Saturday | Opinion
APAC takes centre-stage in AI-driven drug discovery

Drug discovery is a lengthy and costly process, typically requiring billions of dollars and nearly a decade to bring a d...

February 1, 2025 | Saturday | Analysis
GHIT announces $12.7 M worth investment for developing diagnostics and drugs for malaria, NTDs

The Global Health Innovative Technology (GHIT) Fund, headquartered in Japan, has announced a total investment of approxi...

January 31, 2025 | Friday | News
Japan's ThinkCyte expands product portfolio to drive innovation in drug discovery and disease research

Japan-based startup ThinkCyte, a biotechnology company pioneering novel artificial intelligence (AI)-based cell analysis...

January 29, 2025 | Wednesday | News
Australia's Inventia announces groundbreaking advancement in 3D cell culture technology

Inventia Life Science, an innovator in 3D cell culture technologies, has announced the launch of RASTRUM Allegro, a...

January 28, 2025 | Tuesday | News
AB2 Bio signs licensing agreement worth $500 M with Nippon Shinyaku for ultra-rare autoimmune disease treatment

AB2 Bio, a biotechnology company developing innovative therapies for the treatment of severe systemic hyperinflammatory ...

January 28, 2025 | Tuesday | News
Japan's Daiichi Sankyo establishes Smart research lab in US to expedite drug discovery

Japanese pharmaceutical firm Daiichi Sankyo has established a state-of-the-art research laboratory in San Diego, Ca...

January 23, 2025 | Thursday | News
Takeda, Tohoku University form alliance to strengthen drug discovery capabilities in Japan

Takeda Pharmaceutical Company and the Tohoku University Drug Discovery Strategy Promotion Organization have entered into...

December 18, 2024 | Wednesday | News
Eisai and Biogen Japan collaborate to lead dementia genomics R&D with NCNP in Japan

Eisai Co., Ltd. and Biogen Japan Ltd. have announced that Eisai has entered into a research collaboration agreement with...

November 26, 2024 | Tuesday | News
Hong Kong-based Insilico Medicine enters into revolving loan facility of up to $100 M with HSBC

Hong Kong-based Insilico Medicine, a global leading generative artificial intelligence (AI)-driven biotechnology company...

November 5, 2024 | Tuesday | News
Biomedical engineers in Australia design high-speed 3D bioprinter as gamechanger for drug discovery

Biomedical engineers from the University of Melbourne, Australia have invented a 3D printing system, or bioprinter, capa...

November 4, 2024 | Monday | News